Khusial P Raaj, Vadla Bhaskar, Krishnan Harini, Ramlall Trudy F, Shen Yongquan, Ichikawa Hitoshi, Geng Jian-Guo, Goldberg Gary S
Molecular Biology Department, University of Medicine and Dentistry of New Jersey, Stratford, NJ 08084, USA.
Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey, Stratford, NJ 08084, USA.
Oncotarget. 2010 Jul;1(3):198-209. doi: 10.18632/oncotarget.126.
Cell migration is an essential step in cancer invasion and metastasis. A number of orchestrated cellular events involving tyrosine kinases and signaling receptors enable cancer cells to dislodge from primary tumors and colonize elsewhere in the body. For example, activation of the Src and Abl kinases can mediate events that promote tumor cell migration. Also, activation of the Robo1 receptor can induce tumor cell migration. However, while the importance of Src, Abl, and Robo1 in cell migration have been demonstrated, molecular mechanisms by which they collectively influence cell migration have not been clearly elucidated. In addition, little is known about mechanisms that control Robo1 expression. We report here that Src activates Abl to stabilize Robo1 in order to promote cell migration. Inhibition of Abl kinase activity by siRNA or kinase blockers decreased Robo1 protein levels and suppressed the migration of transformed cells. We also provide evidence that Robo1 utilizes Cdc42 and Rac1 GTPases to induce cell migration. In addition, inhibition of Robo1 signaling can suppress transformed cell migration in the face of robust Src and Abl kinase activity. Therefore, inhibitors of Src, Abl, Robo1 and small GTPases may target a coordinated pathway required for tumor cell migration.
细胞迁移是癌症侵袭和转移过程中的一个重要步骤。一系列涉及酪氨酸激酶和信号受体的精心编排的细胞事件,使癌细胞能够从原发性肿瘤脱离并在身体其他部位定植。例如,Src和Abl激酶的激活可以介导促进肿瘤细胞迁移的事件。此外,Robo1受体的激活可以诱导肿瘤细胞迁移。然而,虽然Src、Abl和Robo1在细胞迁移中的重要性已得到证实,但它们共同影响细胞迁移的分子机制尚未得到明确阐明。此外,关于控制Robo1表达的机制知之甚少。我们在此报告,Src激活Abl以稳定Robo1从而促进细胞迁移。通过siRNA或激酶阻滞剂抑制Abl激酶活性会降低Robo1蛋白水平并抑制转化细胞的迁移。我们还提供证据表明,Robo1利用Cdc42和Rac1 GTP酶来诱导细胞迁移。此外,在Src和Abl激酶活性较强的情况下,抑制Robo1信号传导可以抑制转化细胞的迁移。因此,Src、Abl、Robo1和小GTP酶的抑制剂可能靶向肿瘤细胞迁移所需的协同途径。